As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

While industry groups decried the Trump administration’s new drug pricing order, analysts say it lacked details and the teeth ...

Roche committed $50 billion in U.S. manufacturing funds, with which it will construct at least four new facilities.

The package revives President Donald Trump’s much-maligned Most Favored Nations rule but goes further into the private ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

The FDA and CDC have also recommended pausing the use of Ixchiq in seniors 60 years and older while safety investigations are ...

At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a ...

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...

While Quantum computing has been reported to be five years away for many years now, companies are preparing for it by setting ...

To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of ...

A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...

Biopharma venture capital fundraising declined from $8.1 billion in the first quarter of 2024 to $6.5 billion in the first ...